# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA835508 | B | Inhibition of eukaryotic elongation factor-2 kinase mediated [gamma-32P]-ATP incorporation at 10 ug/mL | Homo sapiens | 4 | ALA1145273 | single protein format | Scientific Literature | |
2. | ALA835509 | B | Inhibition of eukaryotic elongation factor-2 kinase mediated [gamma-32P]-ATP incorporation at 1 ug/mL | Homo sapiens | 5 | ALA1145273 | single protein format | Scientific Literature | |
3. | ALA834780 | B | Inhibition of eukaryotic elongation factor-2 kinase mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL | Homo sapiens | 5 | ALA1145273 | single protein format | Scientific Literature | |
4. | ALA836165 | B | Inhibition of eukaryotic elongation factor-2 kinase mediated [gamma-32P]-ATP incorporation at 10 ug/mL; Range is 50-80 | Homo sapiens | 1 | ALA1145273 | single protein format | Scientific Literature | |
5. | ALA856380 | B | Percent residual activity, relative to control, of EF2K at 1 uM concentration of inhibitor in presence of 5 uM ATP | Homo sapiens | 2 | ALA1137240 | single protein format | Scientific Literature | |
6. | ALA937076 | B | Inhibition of eEF2 kinase | 2 | ALA1145498 | single protein format | Scientific Literature | ||
7. | ALA922815 | B | Activity of human eEF-2K kinase at 1 uM | Homo sapiens | 1 | ALA1147076 | single protein format | Scientific Literature | |
8. | ALA970585 | B | Inhibition of EEF2K at 1 uM | 1 | ALA1138512 | single protein format | Scientific Literature | ||
9. | ALA950861 | B | Inhibition of human EF2K at 10 uM | 1 | ALA1137681 | single protein format | Scientific Literature | ||
10. | ALA1004134 | B | Inhibition of EFK2 at 1 uM relative to control | 3 | ALA1136991 | single protein format | Scientific Literature | ||
11. | ALA1061749 | B | Inhibition of eEF-2K at 1 uM | 1 | ALA1154027 | single protein format | Scientific Literature | ||
12. | ALA1061957 | B | Percentage EF2K activity remaining in the presence of 25uM inhibitor | Homo sapiens | 2 | ALA1150976 | single protein format | Scientific Literature | |
13. | ALA1052087 | B | Percentage EF2K activity remaining in the presence of 0.1uM inhibitor | Homo sapiens | 7 | ALA1150976 | single protein format | Scientific Literature | |
14. | ALA1052088 | B | Percentage EF2K activity remaining in the presence of 2uM inhibitor | Homo sapiens | 1 | ALA1150976 | single protein format | Scientific Literature | |
15. | ALA1052089 | B | Percentage EF2K activity remaining in the presence of 3uM inhibitor | Homo sapiens | 1 | ALA1150976 | single protein format | Scientific Literature | |
16. | ALA1060113 | B | Percentage EF2K activity remaining in the presence of 1uM inhibitor | Homo sapiens | 33 | ALA1150976 | single protein format | Scientific Literature | |
17. | ALA1052074 | B | Percentage EF2K activity remaining in the presence of 0.01uM inhibitor | Homo sapiens | 3 | ALA1150976 | single protein format | Scientific Literature | |
18. | ALA1052075 | B | Percentage EF2K activity remaining in the presence of 10uM inhibitor | Homo sapiens | 24 | ALA1150976 | single protein format | Scientific Literature | |
19. | ALA1056915 | B | Inhibition of EF2K assessed as remaining enzyme activity at 3 uM relative to DMSO | 1 | ALA1154183 | single protein format | Scientific Literature | ||
20. | ALA1055339 | B | Inhibition of EF2K assessed as remaining enzyme activity at 1 uM relative to DMSO | 1 | ALA1154183 | single protein format | Scientific Literature |